Fig. 1: MSC-EVs regulate bone-related disease progression through various mechanisms.

These include the regulation of signaling pathways, promotion of osteoblast proliferation, modulation of the extracellular matrix, facilitation of angiogenesis, influence on bone metabolism, and modulation of inflammatory responses.